Cd97 serves as a novel biomarker of immune cell infiltration in hepatocellular carcinoma

HIGHLIGHTS

SUMMARY

    And rapid developments in science and technology, the early detection rate and treatment efficacy of HCC have improved. Chidambaram et_al found that CD97 increased the migration ability of tumor cells in glioblastoma, but with no effect on proliferation, and the survival of patients with CD97 overexpression was significantly shorter than that in patients with lower expression. Next, the authors selected two datasets (GSE14323 and GSE64041 ) containing HCC and normal hepatic tissue gene_expression data from the GEO database. The authors used the TIMER database to analyze TIICs, including CD8+ T_cells, CD4+ T_cells, B cells, macrophages . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?